1,7-dimethylxanthine has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies
1,7-dimethylxanthine : A dimethylxanthine having the two methyl groups located at positions 1 and 7. It is a metabolite of caffeine and theobromine in animals.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
Excerpt | Relevance | Reference |
---|---|---|
"In the second model, in blood of COPD-patients and healthy controls ex vivo pre-incubated with a physiological concentration of 1,7-dimethylxanthine (10microM), LPS-induced production of the cytokines IL-6 and TNF-alpha was significantly suppressed." | 1.36 | Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine. ( Bast, A; Brauers, K; Geraets, L; Haegens, A; Hageman, GJ; Vernooy, JH; Weseler, AR; Wouters, EF, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geraets, L | 1 |
Haegens, A | 1 |
Weseler, AR | 1 |
Brauers, K | 1 |
Vernooy, JH | 1 |
Wouters, EF | 1 |
Bast, A | 1 |
Hageman, GJ | 1 |
1 other study available for 1,7-dimethylxanthine and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine.
Topics: Administration, Oral; Aged; Animals; Anti-Inflammatory Agents; Benzamides; Case-Control Studies; Cyt | 2010 |